An in-depth analysis of four classes of antidepressants quantification from human serum using LC-MS/MS

© 2023. The Author(s)..

Depression is a growing global crisis, with females at a higher rate of diagnosis than males. While the percentage of patients on prescribed antidepressants have tripled over the last two decades, we are still at a crossroad where the discrepancy lies between finding a drug to suit a patient and monitoring the abundance of it in the body to prevent unwanted side effects. Liquid Chromatography tandem mass spectrometry (LC-MS/MS) has garnered the attention of clinicians as a technique to accurately monitor therapeutic drugs in human serum with high specificity and accuracy. This may be a potential solution, but the challenge persists in the realm of sample preparation, where a method is automatable. We have developed and validated an LC-MS/MS-based assay for simultaneous quantification of 4 different classes of commonly prescribed antidepressants in women that is automated using a JANUS G3 Robotic Liquid Handler. Our method utilizes a simple sample preparation technique, utilizing only 20 μL of a serum sample, to accurately measure Bupropion, Citalopram, Desipramine, Imipramine, Olanzapine, Sertraline and Vilazodone across a range of 1.0 to 230 ng/mL. Our method exhibits a linearity of R2 ≥ 0.99 when detected in MRM mode and % CV of ≤ 20% for all analytes across the board. In addition, we have designed a prototype that can be utilized at a clinical mass spectrometry lab and assessed the long-term use of this prototype using an accelerated stability study. Overall, our developed method has the potential to be translated to clinical settings to monitor postpartum depression for a large number of patient samples using automation.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Scientific reports - 13(2023), 1 vom: 06. Feb., Seite 2115

Sprache:

Englisch

Beteiligte Personen:

Fariha, Ramisa [VerfasserIn]
Deshpande, Prutha S [VerfasserIn]
Rothkopf, Emma [VerfasserIn]
Jabrah, Mohannad [VerfasserIn]
Spooner, Adam [VerfasserIn]
Okoh, Oluwanifemi David [VerfasserIn]
Tripathi, Anubhav [VerfasserIn]

Links:

Volltext

Themen:

Antidepressive Agents
Imipramine
Journal Article
OGG85SX4E4
QUC7NX6WMB
Research Support, Non-U.S. Gov't
Sertraline

Anmerkungen:

Date Completed 08.02.2023

Date Revised 17.03.2023

published: Electronic

Citation Status MEDLINE

doi:

10.1038/s41598-023-29229-0

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM352569638